Atrial fibrillation screening using a 14-day wearable heart monitor patch significantly increased diagnoses compared to usual care, according to research presented at ESC 2024.

The PROTEUS trial, presented at ESC 2024, evaluated the effectiveness of AI in standardizing clinician decision-making during stress echocardiography for coronary artery disease

The FDA has formally approved Emergent BioSolutions’ smallpox and mpox vaccine for use in preventing the virus in people at high risk of infection. 

New study shows sulfonamides and cephalosporins carry the highest risk for serious cutaneous adverse drug reactions among antibiotics, particularly in older adults.

Recent research highlights a significant increase in the risk of Barrett’s esophagus following sleeve gastrectomy, a commonly performed bariatric surgery

A recent study finds that a liberal transfusion strategy does not improve neurological outcomes in critically ill patients with traumatic brain injury compared to a restrictive approach.

A study highlights the potential of intestinal ultrasound as a valuable tool for predicting treatment outcomes in children with moderate-to-severe ulcerative colitis.

A multicentre study reveals the efficacy of Venetoclax with hypomethylating agents in treating acute myeloid leukemia in patients aged 80 and older.

Presented at ESC 2024, vutrisiran, an RNAi therapeutic, significantly reduced mortality and cardiovascular events in patients with ATTR-CM.

The deal centres on Lindy’s microglassification technology, which facilitates high-concentration subcutaneous injections of biologic drugs.